Modern commercial data helps organizations
find new patients and HCPs
PLEASANTON, Calif., Dec. 12,
2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today
announced increasing momentum for Veeva Compass Patient, an
emerging leader for anonymous patient longitudinal data. With
unlimited data access, daily data, and the most complete data
network supporting both retail and specialty brands, Compass
Patient helps commercial teams at biopharmas of all sizes better
support key use cases like patient journey, market sizing, and
field force activation.
"We are using Veeva Compass Patient for many of our brands as it
helps us find more HCPs and patients than traditional sources,"
said Sridutta Rao, executive director of commercial data and
analytics solutions at Bayer. "Having unlimited access to a
complete and modern dataset to generate insights for both retail
prescriptions and in-office treatments gives us a better
understanding of the entire patient journey."
Compass Patient is licensed for use at the brand level and
includes unlimited data access to all patient data. The Compass
data network includes more than 300 million patients in the U.S.,
over three million healthcare providers and clinicians, 80+ billion
prescription and medical records, and more than seven years of
patient history.
"Veeva Compass Patient is the next generation of patient data
for life sciences," said Peter
Stark, executive vice president and general manager of Veeva
Compass. "I'm excited to see our customer community growing and
driving so much value through our partnership."
Veeva Compass Suite includes Veeva Compass Prescriber,
projected prescriptions and procedures at the HCP, HCO, and ZIP
level for retail and non-retail products, and Veeva Compass
National, projected prescriptions and procedures at the state and
national level for retail and non-retail products. Veeva Compass is
part of Veeva Data Cloud, the modern, connected data platform for
life sciences, which includes Veeva OpenData and Veeva
Link.
Additional Information
For more on Veeva Compass,
visit: veeva.com/Compass
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10- Q for the period ended October 31, 2024, which you can
find here (a summary of risks which may impact our
business can be found on pages 36 and 37), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Alison
Borris
Veeva Systems
925-226-8821
alison.borris@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/a-growing-number-of-biopharmas-leverage-veeva-compass-patient-to-improve-commercialization-302329758.html
SOURCE Veeva Systems